119 related articles for article (PubMed ID: 32419185)
21. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
22. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
23. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
[TBL] [Abstract][Full Text] [Related]
24. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
25. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
26. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma.
Yoshizaki T; Maruyama Y; Sato H; Furukawa M
Int J Cancer; 2001 Jan; 95(1):44-50. PubMed ID: 11241310
[TBL] [Abstract][Full Text] [Related]
27. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
[TBL] [Abstract][Full Text] [Related]
28. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas].
Xu H; Shi XP; Tang WP; Li LX
Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547
[TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
31. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model.
Maekawa K; Sato H; Furukawa M; Yoshizaki T
Clin Exp Metastasis; 2002; 19(6):513-8. PubMed ID: 12405288
[TBL] [Abstract][Full Text] [Related]
34. Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas.
Wehrhan F; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Kesting M; Weber M
BMC Cancer; 2018 Aug; 18(1):823. PubMed ID: 30115022
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
37. Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).
Albinger-Hegyi A; Stoeckli SJ; Schmid S; Storz M; Iotzova G; Probst-Hensch NM; Rehrauer H; Tinguely M; Moch H; Hegyi I
Int J Cancer; 2010 Jun; 126(11):2653-62. PubMed ID: 19816945
[TBL] [Abstract][Full Text] [Related]
38. Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Cell Biochem; 2006 Apr; 97(5):1036-51. PubMed ID: 16294321
[TBL] [Abstract][Full Text] [Related]
39. [Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].
Liu WJ; Xu L; Zhu XW; Chen XF; Wang H; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Mar; 52(3):188-193. PubMed ID: 28279058
[No Abstract] [Full Text] [Related]
40. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma].
Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K
Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]